About Stella Sarraf
Form D filings for Spinogenix from 2017 to 2024 list Stella Sarraf as executive officer and director.
Form D filings also name Stella Sarraf as CEO and director at Amydis.
Stella Sarraf first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Stella Sarraf in the role, so the role may have started earlier or lasted longer.
Spinogenix, Inc.
Executive officer and director
2017 – 2024 · Los Angeles, CA
Develops experimental medicines for people with neurological and psychiatric conditions.
Key Colleagues at Startups
The people Stella Sarraf works with at each company, as listed on that company's latest Form D.
Spinogenix, Inc. · Form D, Jun 21, 2024
MT
Mervyn Turner
Director
DA
Dan Albosta
Executive officer
PV
Peter Vanderklish
Executive officer
Jerre Stead
Director
Amydis, Inc. · Form D, Dec 28, 2023
CA
Christine Aylward
Director
MT
Mervyn Turner
Director
JK
James Khodabakhsh
Director
Jerre Stead
Director
JC
Jack Thrift, CPA
Executive officer